Page 16 - Flipbook
P. 16
Health‐Related Quality‐of‐life Analysis From the Phase 3 CLEAR Trial of Lenvatinib Plus Pembrolizumab or Everolimus vs Sunitinib for Patients With Advanced Renal Cell Carcinoma
Content of this presentation is the property of the author, licensed by ASCO. Permission required for reuse.
